COVERAGE HUB
$ASND
2 articles in last 30 days
LAST 30 DAYS
2 articles
AVG GRADE
LOW
score: -0.50
SENTIMENT
BULLISH
TOTAL VIEWS
0
2-DAY GRADE TIMELINE
2026-06-11
TODAY
RECENT COVERAGE · 2 ARTICLES
Ascendis Pharma A/S (ASND) Presents at Endocrine Society's Annual Meeting (ENDO 2026) - Slideshow (NASDAQ:ASND) 2026-06-15
Ascendis Pharma (ASND) presented scientific data at the Endocrine Society's annual meeting, a routine conference appearance typical for...
5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism
Ascendis Pharma (ASND) released Phase 2 five-year efficacy data for TransCon PTH, demonstrating sustained systemic benefits in...